Interestana
Home/News/Surgery Underused for PHPT With End-Organ Damage
MedPage Today3 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

Surgery Underused for PHPT With End-Organ Damage

Surgery Underused for PHPT With End-Organ Damage

A large national cohort study involving over 43,000 adults diagnosed with primary hyperparathyroidism (PHPT) has revealed that surgical intervention is significantly underused in patients who have developed end-organ damage as a consequence of the condition. The research, which analyzed data from a national cohort, indicated that only a small percentage of these patients ultimately underwent surgical treatment, despite the presence of documented organ damage.

Primary hyperparathyroidism is a disorder characterized by the overproduction of parathyroid hormone (PTH) by one or more of the four parathyroid glands, leading to elevated calcium levels in the blood (hypercalcemia). This chronic hypercalcemia can have detrimental effects on various organ systems, including the kidneys, bones, and cardiovascular system, manifesting as end-organ damage. Common complications include kidney stones, bone loss (osteoporosis and osteopenia), hypertension, and cardiovascular abnormalities. The study's findings suggest a potential gap in the management of PHPT, particularly for those experiencing severe complications.

While the exact criteria for surgical intervention in PHPT can vary, guidelines generally recommend surgery for patients with symptomatic hypercalcemia, significant hypercalcemia (often defined by serum calcium levels above a certain threshold), evidence of kidney stones or impaired kidney function, bone density loss, or other specific end-organ damage. The study's observation of low surgical rates among patients with documented end-organ damage raises questions about adherence to these guidelines, potential barriers to surgical access, or perhaps a re-evaluation of the risk-benefit profile of surgery in certain complex cases. Further investigation into the reasons behind this underutilization is warranted to ensure optimal patient outcomes.

The study's methodology involved examining a substantial dataset of adult patients diagnosed with biochemically confirmed PHPT. By analyzing this large cohort, researchers aimed to quantify the proportion of patients with PHPT-induced end-organ damage who received surgical treatment. The findings highlight a critical area for improvement in clinical practice, emphasizing the need for better identification of eligible patients and potentially more aggressive management strategies, including surgical options, when appropriate for PHPT with end-organ damage. The implications of these findings could lead to revised clinical pathways and increased awareness among healthcare providers regarding the surgical management of advanced PHPT.

Original source — read the full reporting at the publisher:

Read on MedPage Today

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next